InvestSMART

Telix Pharmaceuticals Limited (ASX: TLX) - Announcements

- Current share price for TLX : $15.580

ASX company news and announcements for Telix Pharmaceuticals Limited (TLX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Telix Pharmaceuticals Limited (TLX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Telix Pharmaceuticals Limited (TLX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Telix Pharmaceuticals Limited (TLX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$5,294 Appendix 3X - Initial Directors Interest Notice 31 Mar 2022 8:54AM $4.290 $15.580 risen by 263.17%
$5,294 Change of Composition of the Telix Board of Directors 31 Mar 2022 8:54AM $4.290 $15.580 risen by 263.17%
$5,294 FDA Orphan Drug Designation for Bone Marrow Conditioning 29 Mar 2022 11:05AM $4.490 $15.580 risen by 246.99%
$5,294 Telix and Xiel Sign U.K. and Ireland Distribution Agreement 29 Mar 2022 8:53AM $4.150 $15.580 risen by 275.42%
$5,294 Cleansing Notice under S708A(5)(e) Corporations Act 24 Mar 2022 8:19AM $5.120 $15.580 risen by 204.30%
$5,294 Application for quotation of securities - TLX 24 Mar 2022 8:19AM $5.120 $15.580 risen by 204.30%
$5,294 Development of Glioblastoma Therapy Program 23 Mar 2022 10:02AM $5.010 $15.580 risen by 210.98%
$5,294 Radiopharmaceutical Production Facility Buildout Commences 22 Mar 2022 9:17AM $4.940 $15.580 risen by 215.38%
$5,294 Cleansing Notice under S708A(5)(e) Corporations Act 14 Mar 2022 8:24AM $4.890 $15.580 risen by 218.61%
$5,294 Application for quotation of securities - TLX 14 Mar 2022 8:24AM $4.890 $15.580 risen by 218.61%
$5,294 Notice Required Under ASX Listing Rule 3.13.1 10 Mar 2022 8:27AM $4.960 $15.580 risen by 214.11%
$5,294 ZIRCON Phase 3 Imaging Study Completes Targets Enrolment 8 Mar 2022 8:46AM $4.650 $15.580 risen by 235.05%
$5,294 Cancellation of Share Purchase Plan 2 Mar 2022 9:05AM $5.160 $15.580 risen by 201.94%
$5,294 FY21 Corporate Governance Statement - replacement 28 Feb 2022 12:12PM $5.110 $15.580 risen by 204.89%
$5,294 Appendix 4G - Key to Governance Disclosures - replacement 28 Feb 2022 12:09PM $5.070 $15.580 risen by 207.30%
$5,294 Cleansing Notice under S708A(5)(e) Corporations Act 28 Feb 2022 9:01AM $5.190 $15.580 risen by 200.19%
$5,294 Application for quotation of securities - TLX 28 Feb 2022 8:58AM $5.190 $15.580 risen by 200.19%
$5,294 2021 Full Year Results Presentation 24 Feb 2022 8:26AM $5.070 $15.580 risen by 207.30%
$5,294 Annual Report for the year ended 31 December 2021 24 Feb 2022 8:26AM $5.070 $15.580 risen by 207.30%
$5,294 Corporate Governance Statement 24 Feb 2022 8:20AM $5.070 $15.580 risen by 207.30%
$5,294 Appendix 4G - Key to Governance Disclosures 24 Feb 2022 8:19AM $5.070 $15.580 risen by 207.30%
$5,294 Appendix 4E - Results for announcement to the market 24 Feb 2022 8:18AM $5.070 $15.580 risen by 207.30%
$5,294 Commercial Distribution Agreement for Illuccix for Australia 16 Feb 2022 9:00AM $5.840 $15.580 risen by 166.78%
$5,294 Ceasing to be a substantial holder 14 Feb 2022 8:13AM $6.360 $15.580 risen by 144.97%
$5,294 Update - Proposed issue of securities - TLX 9 Feb 2022 8:23AM $6.970 $15.580 risen by 123.53%

526 - 550 of 951 results

Page 22 of 39

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.